Related Experiment Video
Updated: Nov 26, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.7K
[Hospital medication adherence scale development in cardiovascular disorders]
K Martin-Latry1, P Latry2, Y Pucheu3
1CHU de Bordeaux, Centre d'exploration, de prévention et de traitement de l'athérosclérose, 33600 Pessac, France; Université Bordeaux, biology of cardiovascular diseases, U1034, 33600 Pessac, France; Inserm, biology of cardiovascular diseases, U1034, 33600 Pessac, France.
Annales Pharmaceutiques Francaises
|December 14, 2020
Summary
A new scale, the Medication Adherence Scale in Cardiovascular disorders (Mascard), effectively assesses medication adherence in hospitalized cardiovascular patients. This tool aids healthcare providers in identifying non-adherence risks.
Area of Science:
- Cardiology
- Pharmacology
- Health Services Research
Background:
- Non-adherence to cardiovascular drugs leads to serious complications in primary and secondary prevention.
- Accurate assessment of medication adherence is crucial for managing cardiovascular disease patients.
Purpose of the Study:
- To develop and validate a new scale for assessing medication adherence in hospitalized patients with cardiovascular diseases.
Main Methods:
- A cohort of 219 high-risk cardiovascular patients was studied.
- The newly developed Medication Adherence Scale in Cardiovascular disorders (Mascard) was used to collect non-adherence data.
- Mascard data were compared with physician assessments and cardiovascular risk factor control.
Main Results:
- The Mascard scale, comprising 5 items, demonstrated good psychometric properties and validity.
- The scale showed a correlation with physician assessments and control of cardiovascular risk factors.
Conclusions:
- The Mascard scale is a rapid and user-friendly tool.
- It can be valuable for healthcare practitioners assessing medication adherence in hospitalized cardiovascular patients.
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
605
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
605
01:15Drug Dosing: Geriatric Patients
115
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
115
01:28Drug Therapy
161
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
161
01:30Heart Failure VII: Nursing Interventions
258
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
258
01:22Heart Failure VI: Adjunct Therapies
119
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
119
01:30Heart Failure V: Medical Management
100
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
100